Protection of mice with vaccinia virus recombinants that express the rabies nucleoprotein
- PMID: 1840709
- DOI: 10.1016/0042-6822(91)90999-r
Protection of mice with vaccinia virus recombinants that express the rabies nucleoprotein
Abstract
The role of rabies virus nucleoprotein (N) in protection against rabies was examined with recombinant vaccinia viruses expressing the N of the Challenge Virus Standard strain. Two chimeric plasmids were constructed with the open reading frame of the N gene placed downstream of the vaccinia P7.5 promoter (early/late class) or the vaccinia P11 promoter (late class), with each expression cassette flanked by vaccinia thymidine kinase (TK) sequences to enable marker rescue by TK insertional inactivation. Two recombinants were isolated that expressed the rabies N in infected cells as determined by radioimmunoprecipitation and immunofluoresence microscopy with an anti-N monoclonal antibody. Two groups of 25 ICR mice inoculated intradermally with the recombinants and challenged with 75 MFPLD50 of street rabies virus showed high survival ratios (22/25 and 21/25). Intramuscular inoculation, however, was not protective against 25 MFPLD50. The intradermally vaccinated mice developed non-neutralizing antibodies against rabies N.
Similar articles
-
Resistance of mice vaccinated with rabies virus internal structural proteins to lethal infection.Arch Virol. 1993;132(1-2):51-65. doi: 10.1007/BF01309843. Arch Virol. 1993. PMID: 8352659
-
Immunogenicity and relative attenuation of different vaccinia-rabies virus recombinants.Arch Virol. 1996;141(6):1055-65. doi: 10.1007/BF01718609. Arch Virol. 1996. PMID: 8712923
-
Protective efficacy in mice of post-exposure vaccination with vaccinia virus recombinant expressing either rabies virus glycoprotein or nucleoprotein.J Gen Virol. 1994 Jun;75 ( Pt 6):1339-44. doi: 10.1099/0022-1317-75-6-1339. J Gen Virol. 1994. PMID: 8207400
-
Target and non-target effects of a recombinant vaccinia-rabies virus developed for fox vaccination against rabies.Dev Biol Stand. 1995;84:183-93. Dev Biol Stand. 1995. PMID: 7796953 Review. No abstract available.
-
Immunoprotection by rabies virus nucleoprotein.Curr Top Microbiol Immunol. 1994;187:161-72. doi: 10.1007/978-3-642-78490-3_9. Curr Top Microbiol Immunol. 1994. PMID: 7532122 Review. No abstract available.
Cited by
-
Resistance of mice vaccinated with rabies virus internal structural proteins to lethal infection.Arch Virol. 1993;132(1-2):51-65. doi: 10.1007/BF01309843. Arch Virol. 1993. PMID: 8352659
-
Comparison of the protective efficacy between single and combination of recombinant adenoviruses expressing complete and truncated glycoprotein, and nucleoprotein of the pathogenic street rabies virus in mice.Virol J. 2017 Jun 24;14(1):122. doi: 10.1186/s12985-017-0789-2. Virol J. 2017. PMID: 28646885 Free PMC article.
-
Rabies vaccine. Developments employing molecular biology methods.Mol Biotechnol. 1999 Apr;11(2):137-47. doi: 10.1007/BF02915807. Mol Biotechnol. 1999. PMID: 10464768 Review.
-
A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection.Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14680-5. doi: 10.1073/pnas.011510698. Proc Natl Acad Sci U S A. 2000. PMID: 11114165 Free PMC article.
-
Induction of protective immunity against coronavirus-induced encephalomyelitis: evidence for an important role of CD8+ T cells in vivo.Eur J Immunol. 1993 Aug;23(8):1757-61. doi: 10.1002/eji.1830230804. Eur J Immunol. 1993. PMID: 8393797 Free PMC article.
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical